Coeliac disease: In vivo toxicity of the putative immunodominant epitope

Gut

Volumn 52, Issue 12, 2003, Pages 1698-1702

  Fraser, J S ^a   Engel, W ^b   Ellis, H J ^a   Moodie, S J ^a   Pollock, E L ^a   Wieser, H ^b   Ciclitira, P J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLIADIN; PEPTIDE FRAGMENT;

AGED; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CELIAC DISEASE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DUODENUM; DUODENUM BIOPSY; FEMALE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTESTINE CELL; INTESTINE VILLUS; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TOXICITY;

AGED; BIOPSY, NEEDLE; CELIAC DISEASE; GLIADIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; PEPTIDE FRAGMENTS;

EID: 0344234245     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.12.1698     Document Type: Article

References (20)

1. Biagi F, Ellis HJ, Parnell ND, et al. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? Aliment Pharmaco Ther 1999;13:945-50.
2. Gjertsen HA, Lundin KE, Sollid LM, et al. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1 Black star0501, beta 1 Black star0201) heterodimer. Hum Immunol 1994;39:243-52.
3. Kontakou M, Przemioslo RT, Sturgess RP, et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995;37:52-7.
4. Lahteenoja H, Maki M, Viander M, et al. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol 2000;95:2880-7.
5. Lundin KE, Sollid LM, Anthonsen D, et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997;112:752-9.
6. Picarelli A, Di Tola M, Sabbatella L, et al. 31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge. Scand J Gastroenterol 1999;34:1099-102.
7. Shidrawi RG, Day P, Przemioslo R, et al. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995;30:758-63.
8. Van De Wal Y, Kooy YM, van Veelen PA, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 1998;95:10050-14.
9. Van De Wal Y, Kooy YM, Van Veelen P, et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 1999;29:3133-9.
10. Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994;343:758-61.
11. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-42.
12. Arenti-Hansen H, Korner R, Molberg O, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603-12.
13. Ellis HJ, Pollock EL, Engel W, et al. T cell studies of the putative immunodominant gluten peptide in coeliac disease. Gut 2003;52:212-17.
14. Shidrawi RG, Parnell ND, Ciclitira PJ, et al. Binding of gluten-derived peptides to the HLA-DQ2 (alpha 1 Black star0501, beta 1 Black star 0201) molecule, assessed in a cellular assay. Clin Exp Immunol 1998;111:158-65.
15. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
16. Bolte G, Osman A, Mothes T, et al. Peptic-tryptic digests of gliadin: contaminating trypsin but not pepsin interferes with gastrointestinal protein binding characteristics. Clin Chim Acta 1996;247:59-70.
17. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-34.
18. Kasarda DD, Okita TW, Bernardin JE, et al. Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum). Proc Natl Acad Sci U S A 1984;81(15):4712-16.
19. Maiuri L, Picarelli A, Boirivant M, et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996;110:1368-78.
20. Molberg O, McAdam S, Lundin KE, et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001;31:1317-23.